These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 1621002)

  • 21. Interleukin 3 and interleukin 3/GM-CSF combination therapy--clinical implications.
    Ganser A; Ottmann OG; Hoelzer D
    Stem Cells; 1993 Nov; 11(6):465-73. PubMed ID: 8111306
    [No Abstract]   [Full Text] [Related]  

  • 22. [Toxicity and hematopoietic regeneration produced by adjuvant chemotherapy in patients with neoplasia of the breast].
    Benet I; Peñarroja C; Ubeda F; Lluch A; Carbonell F; Aguilar N; Alberola V; García-Conde J
    Sangre (Barc); 1988 Jun; 33(3):171-7. PubMed ID: 3175813
    [No Abstract]   [Full Text] [Related]  

  • 23. Chemotherapy dose intensity and quality cancer care.
    Lyman GH
    Oncology (Williston Park); 2006 Dec; 20(14 Suppl 9):16-25. PubMed ID: 17370925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Echinacoside improves hematopoietic function in 5-FU-induced myelosuppression mice.
    Wang S; Zheng G; Tian S; Zhang Y; Shen L; Pak Y; Shen Y; Qian J
    Life Sci; 2015 Feb; 123():86-92. PubMed ID: 25623854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimizing the management of chemotherapy-induced neutropenia.
    Dale DC
    Clin Adv Hematol Oncol; 2003 Nov; 1(11):679-84. PubMed ID: 16258470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Recombinant hematopoietic growth factors in the treatment of various hematologic diseases].
    Pawelski S
    Acta Haematol Pol; 1991; 22(1):186-93. PubMed ID: 1823962
    [No Abstract]   [Full Text] [Related]  

  • 27. Haematopoietic growth factors in the treatment of therapeutic and accidental irradiation-induced bone marrow aplasia.
    Thierry D; Gourmelon P; Parmentier C; Nénot JC
    Int J Radiat Biol; 1995 Feb; 67(2):103-17. PubMed ID: 7533815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relative contributions of marrow microenvironment, growth factors, and stem cells to hematopoiesis in vivo in man. Review of results from autologous stem cell transplant trials and laboratory studies at the Moffitt Cancer Center.
    Elfenbein GJ; Janssen WE; Perkins JB
    Ann N Y Acad Sci; 1995 Dec; 770():315-38. PubMed ID: 8597369
    [No Abstract]   [Full Text] [Related]  

  • 29. Antineoplastic agents and the associated myelosuppressive effects: a review.
    Barreto JN; McCullough KB; Ice LL; Smith JA
    J Pharm Pract; 2014 Oct; 27(5):440-6. PubMed ID: 25147158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical applications of hematopoietic growth factors.
    Vose JM; Armitage JO
    J Clin Oncol; 1995 Apr; 13(4):1023-35. PubMed ID: 7535842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-fluorouracil permits access to a primitive subpopulation of peripheral blood stem cells.
    Rice A; Barbot C; Lacombe F; Dubosc-Marchenay N; Marit G; Hau F; Boiron JM; Reiffers J
    Stem Cells; 1993 Jul; 11(4):326-35. PubMed ID: 8401256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth factors in haematology: prophylactic versus interventional use.
    Boogaerts MA
    Eur J Cancer; 1994; 30A(2):238-43. PubMed ID: 7908820
    [No Abstract]   [Full Text] [Related]  

  • 33. Hematopoietic growth factors.
    Bociek RG; Armitage JO
    CA Cancer J Clin; 1996; 46(3):165-84. PubMed ID: 8646546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Managing chemotherapy-induced bone marrow suppression in cancer.
    Lokich JJ
    Hosp Pract; 1976 Aug; 11(8):61-7. PubMed ID: 1027711
    [No Abstract]   [Full Text] [Related]  

  • 35. [Current treatment methods in myelodysplastic syndromes].
    Klimenko VI; Liubarets TF
    Lik Sprava; 1996; (10-12):20-6. PubMed ID: 9138806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hematopoietic stem cell compartment: acute and late effects of radiation therapy and chemotherapy.
    Mauch P; Constine L; Greenberger J; Knospe W; Sullivan J; Liesveld JL; Deeg HJ
    Int J Radiat Oncol Biol Phys; 1995 Mar; 31(5):1319-39. PubMed ID: 7713791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant human erythropoietin in combination with other hematopoietic cytokines in attenuating chemotherapy-induced multilineage myelosuppression: brief communication.
    Vadhan-Raj S
    Semin Hematol; 1996 Jan; 33(1 Suppl 1):16-8. PubMed ID: 8714611
    [No Abstract]   [Full Text] [Related]  

  • 38. Improvement of icaritin on hematopoietic function in cyclophosphamide-induced myelosuppression mice.
    Sun C; Yang J; Pan L; Guo N; Li B; Yao J; Wang M; Qi C; Zhang G; Liu Z
    Immunopharmacol Immunotoxicol; 2018 Feb; 40(1):25-34. PubMed ID: 29077519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth factors in the management of adult acute leukemia.
    Bernstein SH
    Hematol Oncol Clin North Am; 1993 Feb; 7(1):255-74. PubMed ID: 8449861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone marrow uptake of fluorine-18-fluorodeoxyglucose following treatment with hematopoietic growth factors: initial evaluation.
    Knopp MV; Bischoff H; Rimac A; Oberdorfer F; van Kaick G
    Nucl Med Biol; 1996 Aug; 23(6):845-9. PubMed ID: 8940729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.